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Dear Editor
The epidemiology of the human immunodeﬁ-
ciency virus (HIV) is usually described as low-level,
concentrated, or generalised and these patterns
are characterised by HIV prevalence rates not
consistently exceeding 5% in any deﬁned sub-
population, consistently >5% in at least one deﬁned
sub-population but <1% in pregnant women in
urban areas, or consistently >1% in pregnant
women, respectively [1]. We reported a mater-
nal HIV prevalence rate of 0.23% among pregnant
women attending a major maternity hospital in
Kassala state in eastern Sudan [2]. A recently
published antenatal sentinel sero-surveillance car-
ried out in 15 Sudanese northern states, including
Kassala state, tested 9164 serum samples col-
lected from 26 antenatal care clinics (ANC) and
reported an estimated maternal HIV prevalence
of 0.19% [3]. Moreover, the overall prevalence
of HIV among adults in Sudan has been revised
down to 1.1% and further geographical stratiﬁca-
tion of HIV prevalence revealed an estimate of
0.67% in northern Sudan compared to 3.1% in south-
ern Sudan [3]. It is noteworthy that, for various
geopolitical reasons, the term ‘‘northern Sudan’’
currently refers to 15 states located in central,
northern, eastern and western parts of the coun-
try.
Kassala state has provided refuge to thousands of
internally displaced people as well as refugees from
neighbouring Ethiopia and Eritrea. While Eritrea has
recently made major strides in combating the HIV
epidemic and managed to reduce its maternal HIV
prevalence from 2.5% to 0.66%, Ethiopia has a long
way to go as current ﬁgures suggest a maternal HIV
prevalence of 3.5% [4,5].
The nature of the anonymous unlinked test-
ing strategy has inherently limited our ability
c
t
H
1876-0341/$ — see front matter © 2011 King Saud Bin Abdulaziz University for Health
doi:10.1016/j.jiph.2011.09.003o collect detailed socio-demographic data [2].
e consecutively collected the residues of blood
amples obtained from all women presenting to
assala new maternity hospital (KNMH) which pro-
ides routine as well as emergency care to all
atients without any discrimination or exclusion
ased on ethnicity, religion, disability, or social sta-
us. Although KNMH is based in an urban setting, it
aters for more than 60% of health care provided
or pregnant women in Kassala state including rural
opulation. Unfortunately, currently published HIV
revalence data have not been stratiﬁed by place
f residence and, therefore, we are unable to pro-
ide any further information on rural versus urban
IV prevalence in Sudan [3].
We have already provided information on access
nd utilisation of ANC in Kassala state [2]. In sum-
ary, three quarters of pregnant women in Kassala
tate received ANC on one or more occasions dur-
ng pregnancy and nearly two thirds of them had
blood sample collected for routine clinical pur-
oses. These ﬁndings present local health planners
ith an excellent opportunity for expanding access
o routine HIV antenatal testing on an opt-out basis.
We followed the national HIV testing algorithm
hich relies on serial testing using rapid commer-
ial kits [2]. All kits are included in the World Health
rganisation (WHO) list of approved HIV tests [1].
he suggestion that our HIV results could have
een different if we used a single alternative assay
emains speculative as local validation studies have
o be carried out before arriving to such conclu-
ions. Furthermore, serial HIV testing algorithms,
hich combine speciﬁc tests in a pre-determined
equence, are endorsed by WHO in low-prevalence
ettings such as Sudan [1]. Therefore, relying on a
ingle HIV test, irrespective of its individual valid-
ty estimates, would not be appropriate in Sudan’s
ontext.
Finally, we totally agree with the recommenda-ion that more studies examining various aspects of
IV infection in Sudan are needed and, hopefully,
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heir ﬁndings will be appropriately used to inform
ealth policy making in Sudan.
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